cobalt has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adkins, DR; Kimple, RJ; Michel, LS; Nickel, KP; Redlich, N; Robinson, AM; Stein, AP; Uppaluri, R; Van Tine, BA; Wheeler, DL | 1 |
| KINDLER, W; SCHMIED, G | 1 |
2 other study(ies) available for cobalt and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion Molecules; Cell Line, Tumor; Cetuximab; Cobalt; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Neuregulin-1; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-3; RNA Interference; RNA, Small Interfering; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous | 2018 |
[Unusually early success by exclusive telecobalt therapy in laryngeal and hypopharyngeal carcinoma. (Preliminary report)].
Topics: Carcinoma, Squamous Cell; Cobalt; Cobalt Radioisotopes; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Larynx; Larynx, Artificial; Pharyngeal Neoplasms; Pharynx; Squamous Cell Carcinoma of Head and Neck | 1960 |